Table A3.

Underlying renal diseases for patients with or without ICU stay after KT.

	∑ (n = 105)	ICU Yes (n = 17)	ICU No (n = 88)	p-Value
ADPKD	11 (10.5%)	2 (11.8%)	9 (10.2%)	n.s.
amyloidosis	3 (2.9%)	-	3 (3.4%)	n.s.
analgesic nephropathy	3 (2.9%)	1 (5.9%)	2 (2.3%)	n.s.
chronic glomerulonephritis	23 (21.9%)	1 (5.9%)	22 (25%)	n.s.
cardiac cirrhosis	1 (1%)		1 (1.1%)	n.s.
diabetic nephropathy	17 (16.2%)	2 (11.8%)	15 (17%)	n.s.
FSGS	2 (1.9%)	-	2 (2.3%)	n.s.
goodpasture syndrome	2 (1.9%)	-	2 (2.3%)	n.s.
hypertensive nephropathy	15 (14.3%)	6 (35.3%)	9 (10.2%)	<0.05
IgA nephropathy	3 (2.9%)	-	3 (3.4%)	n.s.
kidney cirrhosis	8 (7.6%)	2 (11.8%)	6 (6.8%)	n.s.
nephrosclerosis	7 (6.7%)	2 (11.8%)	5 (5.7%)	n.s.
other cystic disease	3 (2.9%)	1 (5.9%)	2 (2.2%)	n.s.
renal cell carcinoma	2 (1.9%)	1 (5.9%)	1 (1.1%)	n.s.
vascular nephropathy	7 (6.7%)	3 (17.6%)	4 (4.5%)	n.s.
vasculitis	2 (1.9%)	1 (5.9%)	1 (1.1%)	n.s.
not known	13 (12.5%)	-	13 (14.8%)	n.s.